Partner with us
Studies
/
Exogenous d-β-hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis
Ketone ester/other
Human RCT
2022

Exogenous d-β-hydroxybutyrate lowers blood glucose in part by decreasing the availability of L-alanine for gluconeogenesis

Key finding
Adding 2 g of L-alanine reduced the ketone ester-induced fall in blood glucose from 28 percent to 16 percent, indicating the glucose-lowering effect is partly due to beta-hydroxybutyrate decreasing L-alanine availability for gluconeogenesis.
What the study did

In this crossover study, 10 healthy volunteers fasted for 24 hours and then ingested 25 g of d-beta-hydroxybutyrate as a ketone ester drink on two visits, once with an additional 2 g of L-alanine. The ketone ester raised blood beta-hydroxybutyrate to 4.52 mmol/L, lowered glucose from 4.97 to 3.77 mmol/L, and lowered L-alanine from 0.56 to 0.41 mmol/L. L-alanine supplementation raised blood L-alanine by 0.68 mmol/L and did not significantly affect beta-hydroxybutyrate, L-glutamine, free fatty acids, lactate or C-peptide. It significantly attenuated the ketosis-induced drop in glucose from 28 percent to 16 percent (p < .01).

This study used [form], not goBHB. It is shown here as general ketone science. Only goBHB studies back goBHB product claims.
GOBHB//QUERY_CONSOLE271 STUDIES INDEXED
> Ask what it does, which formats it goes into, or who is already using it.
What does BHB do?goBHB in gummies?Who is using goBHB?
Let me put a person on it

A goBHB specialist picks these up and answers inside one business day.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Ask
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Pharmaceutical grade, 48 patents, and over 300 million doses in market.
Ask me about goBHB